SAGE Therapeutics Company
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Technology:
P4 Medicine
Industry:
Biotechnology, Health Care, Science and Engineering
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
01 01 10
Employees Number:
501-1000
Funding Status:
IPO
Investors Number:
6
Total Funding:
1088000000
Estimated Revenue:
$50M to $100M
Last Funding Date:
27 11 20
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership